In an internal validation set including 706 mild cognitive impairment (MCI) cases and 301 controls, enhancer_CAGE, enhancer_DHS, and promoter_CAGE in the non-coding region of SEPHS2 were found to be associated with MCI (all P < 0.05) (Table S7). Here, SEPHS2 is linked to Cognitive impairment.